^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

MYH7 (Myosin Heavy Chain 7)

i
Other names: MYH7, Myosin Heavy Chain 7, CMD1S, Myosin, Heavy Polypeptide 7, Cardiac Muscle, Beta, MyHC-Beta, Myosin-7, MYHCB, CMH1, MPD1, Myosin Heavy Chain, Cardiac Muscle Beta Isoform, Myosin, Heavy Chain 7, Cardiac Muscle, Beta, Cardiac Muscle Myosin Heavy Chain 7 Beta, Rhabdomyosarcoma Antigen MU-RMS-40.7A, Myosin Heavy Chain Beta-Subunit, Myosin Heavy Chain Slow Isoform, Myopathy, Distal 1, Myhc-Slow, MyHC-Slow, Myosin 7, SPMD, SPMM
Associations
Trials
3ms
FLASH: innovative integrated enzymatic-fluorescent labeling for automated muscle fiber typing, metabolic and morphometric analysis. (PubMed, Skelet Muscle)
FLASH provides an efficient and robust tool for high-throughput skeletal muscle histology. By combining enzymatic and fluorescent co-labeling with machine learning-based image analysis, this method improves reproductibility, reduces experimental complexity, and minimizes user bias. FLASH is particularly well-suited for large-scale or longitudinal studies investigating muscle adaptation in health and disease.
Journal
|
MYH4 (Myosin Heavy Chain 4) • MYH7 (Myosin Heavy Chain 7)
3ms
Hypertrophic Cardiomyopathy Mimicking a Primary Cardiac Tumor: Case Report and Review of Molecular Genetic Findings. (PubMed, Am J Forensic Med Pathol)
ALPK3 (alpha protein kinase 3) has been identified as a gene of interest in HCM, specifically associated with late-onset adult HCM or pediatric cases which typically present with musculoskeletal and facial deformities. In this report, we present a case of SCD due to HCM in a young, reportedly asymptomatic patient without dysmorphia that had a specific mutation of the ALPK3 gene and a striking gross pathological appearance previously undiscussed in literature.
Review • Journal
|
MYH7 (Myosin Heavy Chain 7)
4ms
Tumor mutational burden, gene expression patterns, and immune-cell deconvolution in testicular germ cell tumors. (PubMed, Transl Androl Urol)
GSEA indicated that TMB and TMB-related hub genes (FOXA2, IRX3, MYH7, and TNNT2) were all highly associated with immune-related function. Our findings could provide a better understanding of the progression of TGCT and identify potential biomarkers or drug targets for TGCT.
Journal • Tumor mutational burden
|
TMB (Tumor Mutational Burden) • FOXA2 (Forkhead Box A2) • MYH7 (Myosin Heavy Chain 7)
5ms
Additive cardioprotection by dapagliflozin and pioglitazone co-therapy in streptozotocin-induced diabetic rats. (PubMed, J Pharm Pharmacol)
Combined dapagliflozin and pioglitazone protect diabetic rat hearts by reducing oxidative stress, inflammation, and apoptosis, independently of glycemic control. This combination therapy offers a promising approach to mitigate cardiovascular complications in diabetes.
Preclinical • Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • BAX (BCL2-associated X protein) • MYH7 (Myosin Heavy Chain 7) • SOD2 (Superoxide Dismutase 2)
5ms
Integrating genomic mutations and tumor-infiltrating lymphocytes improves prediction of response to trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer. (PubMed, Cancer Drug Resist)
Genomic alterations and reduced TIL density underpin trastuzumab resistance. The novel TRAG signature and integrated prognostic model enhance risk stratification and may guide personalized adjuvant therapy in early-stage HER2+ BC.
Journal • Tumor-infiltrating lymphocyte • BRCA Biomarker
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • BRCA1 (Breast cancer 1, early onset) • FBXW7 (F-Box And WD Repeat Domain Containing 7) • PAPPA2 (Pappalysin 2) • NCOR2 (Nuclear Receptor Corepressor 2) • MAP1A (Microtubule Associated Protein 1A) • MYH7 (Myosin Heavy Chain 7)
|
HER-2 positive
|
Herceptin (trastuzumab)
7ms
User testing of a previsit chatbot developed for population genomic screening and counseling. (PubMed, J Genet Couns)
Overall, participants perceived the PV chatbot to be of value in educating and preparing them for GC and reflected on how the PV chatbot may have enhanced GC. Many of the perceived benefits of this chatbot are applicable across GC settings.
Journal • BRCA Biomarker
|
BRCA2 (Breast cancer 2, early onset) • PALB2 (Partner and localizer of BRCA2) • PMS2 (PMS1 protein homolog 2) • MYH7 (Myosin Heavy Chain 7)
7ms
Molecular Basis of Aggressiveness in Pituitary Adenomas and Its Association With the Immune Microenvironment. (PubMed, Int J Genomics)
Next, we determined MYH7 as an accurate diagnostic marker, and the immune infiltration analysis revealed that MYH7 expression was negatively correlated with stromal score and immune score but positively correlated with the infiltration of antitumor cells. We developed a novel marker with a strong diagnostic performance for PAs, providing novel insights for the detection and individualized treatment of PAs.
Journal
|
MYH7 (Myosin Heavy Chain 7)
7ms
Development of an efficient mice model of cancer-associated cardiac cachexia. (PubMed, Animal Model Exp Med)
This work establishes a preclinical framework for targeting ubiquitin pathways to mitigate the morbidity of cancer-related cardiopathy. Our integrated approach delineates a hierarchical progression from subcellular dysfunction to macroscopic cardiac deterioration.
Preclinical • Journal
|
MYH7 (Myosin Heavy Chain 7)
1year
Comprehensive bioinformatics and machine learning analyses for breast cancer staging using TCGA dataset. (PubMed, Brief Bioinform)
Bioinformatics and machine learning meet in this study to find potential biomarkers that influence the progression of breast cancer. The combination of sophisticated analytical methods and extensive genomic datasets presents a promising path for expanding our understanding and enhancing clinical outcomes in identifying and categorizing this intricate illness.
Journal • Machine learning
|
MYH7 (Myosin Heavy Chain 7)
over1year
Secondary findings in 443 exome sequencing data. (PubMed, Ann Hum Genet)
Thirteen of above mentioned variants were classified as known pathogenic and four as expected pathogenic. The information collected in our study may lead to the prevention of severe morbidity and mortality and provides additional insight into the genetic background of the Serbian population.
Journal • BRCA Biomarker
|
BRCA1 (Breast cancer 1, early onset) • PALB2 (Partner and localizer of BRCA2) • MSH2 (MutS Homolog 2) • MYH7 (Myosin Heavy Chain 7)
over1year
A novel 3D cardiac microtissue model for investigation of cardiovascular complications in rheumatoid arthritis. (PubMed, Stem Cell Res Ther)
The cMTs model may represent an advanced human stem cell-based platform for modeling CV complications in RA. The highly developed capillary-like structures observed within RA cMTs highlight a critical feature of inflammation-induced CV dysfunction in chronic inflammatory diseases.
Journal
|
VIM (Vimentin) • CD31 (Platelet and endothelial cell adhesion molecule 1) • DDR2 (Discoidin domain receptor 2) • PECAM1 (Platelet And Endothelial Cell Adhesion Molecule 1) • CDH5 (Cadherin 5) • MYH7 (Myosin Heavy Chain 7)
|
CD31 expression • VIM expression
over1year
When the liver is in poor condition, so is the heart - cardiac remodelling in MASH mouse models. (PubMed, Clin Sci (Lond))
Liver disease, and likely not overfeeding or aging alone, is associated with this cardiac phenotype. Our findings support foz/foz mice as suitable for studying links between MASH and heart structural changes ahead of heart failure.
Preclinical • Journal
|
COL1A1 (Collagen Type I Alpha 1 Chain) • COL3A1 (Collagen Type III Alpha 1 Chain) • MYH7 (Myosin Heavy Chain 7) • SLC2A1 (Solute Carrier Family 2 Member 1)